Mirae Asset Venture Investment

Mirae Asset Venture Investment is a South Korea-based asset management firm founded in 1997, with a global presence spanning 12 countries, including Australia, the United States, and various Asian markets. The company focuses on providing innovative investment solutions and financial strategies tailored to meet the diverse needs of its clients. Its offerings encompass traditional equity and fixed income products, exchange-traded funds, and alternative strategies such as hedge funds. Committed to ethical standards and client-centric principles, Mirae Asset emphasizes teamwork and the recruitment of top talent to drive its success. The firm aims to identify value-generating investment opportunities while adhering to a philosophy centered on building strong, lasting relationships within the communities it serves.

Hyeon-Joo Park

Founder

Suhyung Yoo

Venture Capitalist (Senior Manager)

Past deals in Series B

Class 101

Series B in 2024
Class101 Inc. is an online platform based in Seoul, South Korea, that specializes in providing hobby classes and materials. Founded in 2015, the company offers a diverse range of online courses, including crafting, yoga, calligraphy, drawing, and cooking. Its platform allows users to acquire new skills and explore personal interests from experienced practitioners in their respective fields. By facilitating access to various hobby-related educational resources, Class101 enables individuals to learn at their own pace and convenience, making it easier to integrate education into their daily lives.

Gwanak Analog

Series B in 2024
Gwanak Analog is a company specializing in the design and supply of high-performance power and analog system-on-chip (SoC) and sensor products. It focuses on creating analog and power semiconductors for various applications, including industrial, telecommunications, automotive, and consumer sectors. By leveraging advanced power semiconductor design technology alongside digital signal processing techniques, Gwanak Analog aims to enhance power efficiency in its products. The company’s innovations help clients reduce overall energy consumption in their systems, providing environmentally sustainable and compact solutions.

LN Robotics

Series B in 2024
LN Robotics is a technology research firm focused on developing advanced robotic solutions for the healthcare industry. The company specializes in creating surgical robots tailored for various medical applications, including cardiovascular interventions, single-hole surgeries in the oral cavity, and endoscopic procedures in urology. By addressing specific clinical needs, LN Robotics aims to enhance the effectiveness and precision of surgical procedures, ultimately improving patient outcomes and supporting medical professionals in their practices.

Datarize

Series B in 2024
Datarize is a company based in Seoul, South Korea, specializing in marketing automation solutions tailored for the commerce industry. Founded in 2019, it offers data-driven software-as-a-service (SaaS) solutions that facilitate the analysis of customer behavior in real time. Datarize provides tools such as action banners for website visitors and targeted messages for potential customers who have not engaged with the site. By leveraging complex data analysis, the company enables businesses to enhance customer engagement and effectively manage their marketing campaigns through various automated strategies.

Avelos Therapeutics

Series B in 2024
Avelos Therapeutics is a clinical-stage precision medicine company specializing in the development of targeted therapeutics for cancer treatment. They focus on creating biomarker-driven therapies centered around cell cycle regulation, DNA damage response, and historically 'undruggable' cancer targets. The company aims to enable more effective cancer treatments by identifying and targeting specific biomarkers.

TGS

Series B in 2024
TGS is a manufacturing company that designs copper-carbon composite materials and heat spreader for the oil and gas industry.

Upstage

Series B in 2024
Upstage AI is a startup that specializes in providing customized artificial intelligence services to businesses. The company develops tailored AI models designed to address specific challenges faced by its clients, thereby enhancing operational efficiency and fostering innovation. By enabling organizations to focus on their core tasks, Upstage AI helps them leverage AI technology to solve problems and advance their business processes effectively.

Rebellions

Series B in 2024
Rebellions.ai is a developer of artificial intelligence semiconductor-based solutions focused on creating AI accelerators that connect core semiconductor architectures with deep learning algorithms. The company aims to deliver domain-specific AI processors alongside optimized software, effectively bridging the gap between silicon technology and advanced AI applications. By re-architecting AI processors to integrate specialized deep learning kernels, Rebellions enables clients to utilize energy-efficient AI hardware that seamlessly integrates into their operations. This approach allows clients to maximize the potential of their silicon resources while enhancing performance in AI-driven tasks.

​Orange Square

Series B in 2024
​Orange Square is a fintech platform that offers prepaid cards and mobile wallets for travelers.

Levit

Series B in 2023
Mobile commerce app that allows customers to have an enjoyable and affordable shopping experience

ON

Series B in 2022
ON, established in 2009 and based in San Francisco, specializes in developing mobile applications for sports fans. Its primary product is a platform that facilitates real-time communication with friends about favorite teams, along with news updates, scores, and highlights.

Xinhuazhang Technology

Series B in 2022
X-EPIC offers a solution that aims to revolutionize EDA technology with a focus on intelligence and innovation. X-EPIC's key technological pillars include Intelligent Debug, Intelligent Compiler, Intelligent Cockpit, and Intelligent Cloud Native. Additionally, their solution encompasses seven verification aspects, including hardware emulation system, FPGA-based prototyping, smart scenario stimulus, formal verification, logic simulation, System debugging, and Verification Cloud, offering clients a comprehensive verification solution. X-EPIC also provides professional verification consulting services to support the effective implementation of its solution.

AmazeVR

Series B in 2022
AmazeVR is a virtual concert platform that specializes in the creation and distribution of immersive music content using proprietary technologies. Founded in 2015 by former executives of a prominent mobile platform company, AmazeVR offers an end-to-end solution that transforms the concert experience through ultra-high-resolution custom cameras, cloud-based creation tools, and interactive social features that allow fans to engage as avatars. The platform enables artists to connect more closely with their audiences by facilitating both online and offline concert experiences, adhering to safety measures. Through its innovative approach, AmazeVR aims to redefine how music fans experience live performances, making them more accessible and engaging.

C-BIOMEX

Series B in 2022
C-Biomex is a biotech drug development company specializing in innovative theranostic technology aimed at advancing the treatment of cancer and age-related inflammatory diseases. The company's proprietary approaches enable simultaneous diagnosis and therapy, addressing conditions such as renal cell carcinoma, solid tumors, prostate cancer, and neuroendocrine cancer. By focusing on overcoming the limitations of current diagnostic and treatment methods for kidney cancer and other diseases, C-Biomex aims to enhance patient outcomes and improve the overall efficacy of cancer therapies.

Rael

Series B in 2022
Rael is a Los Angeles-based company that specializes in menstrual care and feminine wellness, offering a range of high-quality products made from natural and organic ingredients. Founded by three female entrepreneurs, Rael aims to empower women by providing safe and healthy alternatives to conventional feminine care items. The product line includes organic cotton pads, pantyliners, tampons, period underwear, feminine washes, and wipes, all designed to meet everyday personal care needs. Additionally, Rael has ventured into the clean beauty sector with its "period beauty" products. Since its establishment in 2017, the company has gained significant traction, becoming a bestseller on Amazon and expanding its availability to 13 countries, including retail partnerships with Target. Rael's commitment to delivering chemical-free and effective products reflects its mission to prioritize women's health and well-being in the feminine care industry.

NextBillion

Series B in 2022
NextBillion is a company focused on fostering development through an open forum platform that facilitates discussion around business models and innovations aimed at addressing challenges in low and middle-income countries. By publishing guest-written content from a diverse array of contributors, including entrepreneurs, investors, and researchers, NextBillion equips its audience with valuable insights into the opportunities and obstacles present in developing markets. The platform serves as a resource for understanding and implementing effective business strategies that can stimulate growth and development in these regions, ultimately supporting enterprises and initiatives that operate on the ground.

Puzzle AI

Series B in 2022
Puzzle AI is a technology company focused on enhancing medical services through the application of artificial intelligence and voice recognition. The company has developed a medical AI platform aimed at improving the working environment for healthcare professionals while elevating the quality of care provided to patients. By leveraging advanced voice recognition and security technologies, Puzzle AI facilitates remote consultations, allowing clients to effectively address their telemedicine needs. This innovative approach not only streamlines communication between medical staff and patients but also supports the growing demand for remote treatment solutions in the healthcare sector.

Novelty Nobility

Series B in 2022
Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.

Quarterback Group

Series B in 2022
Quarterback Group is an investment platform for assets through mobile.

SemiFive

Series B in 2022
SemiFive is a processor design company based in Seongnam-si, South Korea, specializing in custom silicon solutions and RISC-V Core intellectual property. The firm is recognized for pioneering platform-based system-on-chip (SoC) design, providing configurable domain-specific architectures and pre-validated key IP pools to streamline the development process. SemiFive collaborates closely with customers to translate innovative concepts into tailored semiconductor solutions, significantly reducing costs and risks associated with chip design. With robust partnerships, particularly with Samsung Foundry, it offers comprehensive end-to-end capabilities for various applications, including consumer and industrial Internet of Things (IoT), data centers, and artificial intelligence. This integrated approach enables faster realization of custom SoCs, catering to diverse client requirements efficiently.

Cyrus Therapeutics

Series B in 2022
Cyrus Therapeutics is a biotechnology company focused on the research and development of innovative drugs aimed at addressing chronic and life-threatening diseases with significant unmet medical needs. Incorporated in 2019 and based in Seoul, South Korea, the company specializes in discovering and developing molecular medicines for conditions related to metabolism, obesity, metastasis, and refractory issues. Utilizing a range of advanced drug modalities, including traditional small molecule inhibitors and targeted protein degraders, Cyrus Therapeutics is dedicated to developing treatment options for patients who are often considered undruggable.

AmazeVR

Venture Round in 2022
AmazeVR is a virtual concert platform that specializes in the creation and distribution of immersive music content using proprietary technologies. Founded in 2015 by former executives of a prominent mobile platform company, AmazeVR offers an end-to-end solution that transforms the concert experience through ultra-high-resolution custom cameras, cloud-based creation tools, and interactive social features that allow fans to engage as avatars. The platform enables artists to connect more closely with their audiences by facilitating both online and offline concert experiences, adhering to safety measures. Through its innovative approach, AmazeVR aims to redefine how music fans experience live performances, making them more accessible and engaging.

Creatrip

Series B in 2021
Creatrip is a travel information platform designed to enhance the experience of foreign visitors exploring local tourism. The application provides comprehensive access to tourism courses and information across various destinations, facilitating informed travel decisions. It offers features such as ticket reservations, tour bookings, and transportation options, presented in multiple languages to cater to a diverse audience. By allowing users to gather and assess local tourism information, Creatrip empowers tourists to plan their journeys according to their preferences and budget, ultimately making travel both interesting and enjoyable.

Vastai Technologies

Series B in 2021
Vastai Technologies is a company that specializes in the development of semiconductor chips aimed at enhancing computer vision and video processing capabilities. By creating advanced AI chips, Vastai Technologies provides the necessary computing power for artificial intelligence visual applications. This enables manufacturers of computer devices to integrate cutting-edge chip technology into their products, thereby improving performance in various AI-driven tasks. The company's focus on optimizing these technologies positions it as a key player in the semiconductor industry, particularly in applications related to video and image analysis.

S2W

Series B in 2021
S2W is a company focused on cybersecurity data analysis, specifically in the realm of cyber threat intelligence. It has developed advanced data intelligence technology aimed at reducing the impact of cyber threats and cybercrime. The company's offerings include an AI-based multi-domain analytic engine that addresses significant issues such as the illegal trading of sensitive information, including credit card details, passport data, and other confidential materials. By providing enhanced tools for network security researchers, S2W enables more effective prevention and mitigation of cybercrime and related threats on a global scale.

Connecting

Series B in 2021
Connecting is a real-time voice-talk service company that focuses on facilitating meaningful conversations among individuals. It has developed a social calling application that allows users to define their preferences, including hobbies, age, region, and gender, to enhance the matching process. By leveraging a specialized algorithm, the application connects users with others who share similar interests and criteria, enabling them to engage in hassle-free conversations. This innovative approach aims to create a more personalized and fulfilling social interaction experience for its users.

Class 101

Series B in 2021
Class101 Inc. is an online platform based in Seoul, South Korea, that specializes in providing hobby classes and materials. Founded in 2015, the company offers a diverse range of online courses, including crafting, yoga, calligraphy, drawing, and cooking. Its platform allows users to acquire new skills and explore personal interests from experienced practitioners in their respective fields. By facilitating access to various hobby-related educational resources, Class101 enables individuals to learn at their own pace and convenience, making it easier to integrate education into their daily lives.

Catch Fashion

Series B in 2021
Catch Fashion is an e-commerce platform that specializes in selling a wide range of fashionable apparel and accessories. The company offers a diverse selection of products, including shoes, bags, jackets, caps, sweatshirts, boots, evening wear, jeans, and shoulder bags. By featuring items from both local and well-known brands, Catch Fashion aims to provide customers with the latest trends and styles, catering to various fashion preferences. The platform is designed to enhance the online shopping experience, allowing consumers to easily browse and purchase fashionable items that suit their individual tastes.

Jupiter

Series B in 2021
Jupiter is a digital retail bank based in Mumbai, India, that offers a unique co-created banking experience tailored specifically for Millennials. Established in 2019, it provides a comprehensive digital banking application that enables users to efficiently manage their finances. The application assists users in tracking expenses by offering insights into their spending habits and savings growth. Additionally, Jupiter facilitates automated savings, loans, and debit card services, along with 24/7 customer support to enhance user convenience. Through its focus on user-friendly financial management, Jupiter aims to revolutionize the banking experience for the younger generation.

Publy

Series B in 2021
Publy is a content platform tailored for working individuals, focusing on providing subscription services for curated content. The platform allows users to create, design, archive, store, and publish custom content and events. By facilitating the purchase and reservation of content from various media sources, Publy empowers users to access and utilize both current and forthcoming materials. This innovative approach aims to enhance the way professionals engage with and manage content in their work environments.

TWC

Series B in 2021
TWC provides IT solutions, HR, consulting and optimized business operation services by incorporating artificial intelligence.

Fitpet

Series B in 2021
Fitpet is a developer of a veterinary application focused on enhancing the quality of life for companion animals and their caregivers through technological innovation. The application provides real-time insights into a pet's health status by conducting a comprehensive analysis of various parameters, allowing pet owners to better understand and manage their pets' well-being. Committed to fostering a sustainable and pet-friendly society, Fitpet aims to leverage information technology to improve the overall care experience for both pets and their human companions.

Cookat

Series B in 2021
Cookat is a digital content creator specializing in food and culinary trends, focused on delivering engaging videos and unique recipes. The company operates a food blogging platform optimized for mobile users, allowing it to effectively share visually appealing food content across social media channels. By providing a space for food enthusiasts to explore innovative recipes and gourmet ideas, Cookat enhances consumer engagement and promotes the latest culinary trends. In addition to content creation, the platform facilitates the sale of wholesale items, including restaurant advertisements and home meal replacements, connecting consumers within the food market.

Hince

Series B in 2021
Hince is a cosmetics brand that specializes in a diverse range of personal care products, including skin, lip, eye, and face care items. The company focuses on developing mood narrative makeup products, which encompass lipsticks, compacts, eye shadows, and lip glosses. Hince emphasizes the use of natural and vegan ingredients in its offerings, catering to consumers who seek environmentally friendly and ethical options in their beauty routines. By providing a variety of high-quality cosmetics, Hince aims to enhance the beauty experience for its customers while promoting a commitment to sustainability.

Gbike

Series B in 2021
Gbike is a mobility sharing startup in Korea, innovating green urban mobility in Korea where currently car-centric environment. Our service includes bike and scooter sharing with IT services specialized for Korean market & Asia, Pacifics.

AmazeVR

Series B in 2021
AmazeVR is a virtual concert platform that specializes in the creation and distribution of immersive music content using proprietary technologies. Founded in 2015 by former executives of a prominent mobile platform company, AmazeVR offers an end-to-end solution that transforms the concert experience through ultra-high-resolution custom cameras, cloud-based creation tools, and interactive social features that allow fans to engage as avatars. The platform enables artists to connect more closely with their audiences by facilitating both online and offline concert experiences, adhering to safety measures. Through its innovative approach, AmazeVR aims to redefine how music fans experience live performances, making them more accessible and engaging.

Iris.TV

Series B in 2021
IRIS.TV, Inc. is a Los Angeles-based company that specializes in developing a cloud-based personalized video programming system designed to enhance user engagement and increase video views across multiple devices. Founded in 2009, the company offers a suite of products that include Adaptive Stream, which allows for real-time personalized streaming tailored to specific business and editorial guidelines, and Asset IQ, which automates data structuring and asset optimization. Additionally, IRIS Vision provides business intelligence and programming management tools. By leveraging artificial intelligence and machine learning, IRIS.TV automates the delivery of personalized content based on audience preferences and behaviors, thereby improving the viewing experience and operational efficiency for web, mobile, and over-the-top video distribution. The company's platform also facilitates video data connectivity for enhanced advertising outcomes and audience insights, making it a vital resource for publishers, advertisers, and content owners.

Novelty Nobility

Series B in 2021
Novelty Nobility Inc. is a private biotech company dedicated to researching novel angiogenesis targets and developing antibody-based therapeutics, particularly in the fields of ophthalmology and oncology. The company has identified Stem Cell Factor (SCF) and c-KIT as significant angiogenesis targets, which are linked to the proliferation and survival of hematopoietic stem cells. By focusing on the anti-SCF/c-KIT pathway, Novelty Nobility aims to address the unmet medical needs associated with existing anti-VEGF treatments, specifically regarding efficacy and long-term safety. The company is actively engaged in developing therapeutic antibodies and antibody-drug conjugates to combat drug resistance and the negative effects of aberrant blood vessel growth in conditions such as retinal diseases and solid tumors. Their lead candidate, NN2101, a full-human monoclonal antibody, is currently in preclinical development and is supported by strong patent protection in the United States and South Korea.

ImmunoMet Therapeutics

Venture Round in 2021
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, dedicated to developing and commercializing innovative oncology drugs. Founded in 2015, the company focuses on improving the quality of life for cancer patients through its advanced pipeline of products. This includes metabolic regulators designed to target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors aimed at anti-cancer effector T cells. With over six years of expertise in cancer metabolism and immunometabolism, ImmunoMet Therapeutics is positioned to make significant contributions to the field of oncology.

Onul-hoi

Series B in 2021
Onul-Hoi is a mobile commerce platform specializing in the same-day delivery of fresh fish products sourced directly from domestic fisheries. The company operates an online food delivery service that allows customers to order seasonal seafood and receive it on the same day. In addition to fresh fish, Onul-Hoi provides a selection of seafood dishes, ensuring a comprehensive offering for consumers seeking convenient and high-quality seafood options delivered to their homes.

N.CODE

Series B in 2021
D.Code operates an e-commerce platform that connects customers directly with European luxury boutiques, offering a diverse selection of over 700 luxury brands and 100,000 items. The platform provides accurate product information, detailed descriptions, and competitive pricing, typically around 20% lower than retail prices in Korea. In addition to its curated shopping experience, D.Code offers personalized concierge services to enhance customer satisfaction. The company utilizes customer data to develop a fashion trend algorithm, enabling better purchasing decisions and assisting sellers with product sourcing and marketing strategies. By collaborating directly with luxury boutiques, D.Code ensures high-quality service and reasonable pricing, creating an efficient marketplace for luxury goods.

iGinet

Series B in 2020
iGinet is an AI-based insuretech company that creates a virtuous cycle structure of an advanced insurance ecosystem.

Perigee Aerospace

Series B in 2020
Perigee Aerospace is a developer of a orbital launch vehicle.

EVOS Esports

Series B in 2020
EVOS Esports is an eSports organization focused on developing an online sports platform aimed at enhancing the eSports landscape in Southeast Asia. The company provides essential infrastructure to support professional players and content creators, fostering an environment that promotes professionalism across various competitive gaming disciplines. EVOS Esports offers a comprehensive structure for its teams, which includes in-game coaching, dedicated training facilities, and mental wellness support. This commitment to player development and well-being positions EVOS Esports as a significant player in the rapidly evolving eSports industry.

Brandi

Series B in 2020
Brandi is a vertical commerce company founded in 2014 and headquartered in Seoul, South Korea. It operates a retail platform specializing in the fashion and beauty sectors, providing both B2C and B2B shopping experiences. Brandi offers a diverse range of products, including clothing, cosmetics, and home interior items. The company focuses on creating a connected ecosystem that links manufacturers, wholesalers, and consumers, thereby aiding young individuals in engaging with current fashion trends. Through its platform, Brandi aims to make various clothing brands accessible to customers at affordable prices.

Jeongyookgak

Series B in 2020
Jeongyookgak is a company that specializes in the production and sale of fresh meat and groceries. It offers a variety of food items, including pork, beef, eggs, and grass-fed meat, catering to customers seeking high-quality and healthy food options. The company emphasizes rapid delivery services, ensuring that customers receive their orders promptly. By providing online assistance for food delivery, Jeongyookgak aims to meet the growing demand for convenient access to fresh food at reasonable prices.

Pharos iBio

Series B in 2020
Pharos iBio Co. is a company focused on the development of innovative treatments for rare and intractable diseases. Utilizing a cutting-edge drug development platform that incorporates big data and artificial intelligence, Pharos iBio aims to address significant unmet medical needs. The company’s product pipeline includes several candidate drugs, such as PHI-101-AML for refractory or relapsed acute myeloid leukemia, PHI-101-OC for platinum-resistant or refractory ovarian cancer, and PHI-101-TNBC for metastatic triple-negative breast cancer. Additionally, Pharos iBio is advancing other candidates, including PHI-201, PHI-301, and PHI-501, as part of its commitment to improving patient outcomes in challenging therapeutic areas.

StradVision

Series B in 2019
StradVision, established in 2014, specializes in developing perception algorithms for advanced driver assistance systems (ADAS) and autonomous vehicles. Headquartered in San Jose, USA, with R&D centers globally including South Korea, the company offers SVNet External for external object detection and SVNet Internal for occupant monitoring. Its Auto Labeling Tool automates object annotation for training data generation. StradVision's machine learning algorithms have achieved top performance in global tech evaluations, running smoothly on embedded devices. With over 60 issued patents and extensive industry backing, the company aims to democratize self-driving technology through safe, accurate real-world perception capabilities.

Hummingbird Bioscience

Series B in 2019
Hummingbird Bioscience is a biotechnology company specializing in the development of novel therapeutic antibodies for oncology and immuno-oncology indications. Utilizing systems biology approaches and proprietary computational platforms, they discover and engineer innovative biotherapeutics targeting challenging disease pathways with strong biological validation. Their pipeline includes lead assets HMBD-001 (anti-HER3) and HMBD-002 (anti-VISTA), both in cancer treatment. The company has formed strategic partnerships with Cancer Research UK and Amgen, and received a product development grant from the Cancer Prevention and Research Institute of Texas.

Bigpicture

Series B in 2019
Bigpicture is a company focused on the e-sports industry, developing educational software aimed at aspiring professional gamers. It produces informative content, including videos and documentaries, to enhance the knowledge and skills of gamers. In addition to educational resources, Bigpicture manages e-sports teams and organizes online tournaments in collaboration with major game developers. The company strives to create a comprehensive platform that offers gamers opportunities to connect and compete, both online and offline, thereby enriching the overall e-sports experience.

Coinplug

Series B in 2019
Coinplug, Inc. is a South Korean company established in 2013 that specializes in blockchain technology and offers a range of services and solutions. It operates a cryptocurrency exchange platform known as CPDAX, along with an electronic wallet service and an online point-of-sale solution. Coinplug also provides Metadium, a verification platform utilizing blockchain technology, and CP Cube, which serves as a B2B platform for blockchain and public key infrastructure services. Additionally, the company offers SBI Cosmoney, an international remittance service, and CP Solution, a blockchain platform for identity verification. With a strong focus on innovation, Coinplug has developed over 300 blockchain patents and is dedicated to advancing solutions in areas such as identity and authentication, payment processing, and asset management.

QANDA(Mathpresso)

Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

Arcellx

Series B in 2019
Arcellx is a clinical-stage biotechnology company focused on developing innovative immunotherapies, particularly in the realm of cell therapy, for patients with cancer and other serious diseases. The company aims to enhance the safety, effectiveness, and accessibility of these therapies. Arcellx's lead product candidate, CART-ddBCMA, is currently being investigated in a Phase 1 clinical trial for the treatment of relapsed or refractory multiple myeloma. This therapy has received several designations from the U.S. Food and Drug Administration, including Fast Track and Orphan Drug status. Additionally, Arcellx is progressing its dosable and controllable CAR-T therapy, known as ARC-SparX, through two clinical programs targeting relapsed or refractory multiple myeloma and acute myeloid leukemia. Through these efforts, Arcellx seeks to contribute significantly to the advancement of cell therapy in modern medicine.

Wantedlab

Series B in 2019
Wantedlab, Inc. operates a crowd recruiting platform that enables users to refer job applicants to companies and earn rewards when those applicants are hired. Founded in 2015 and headquartered in Seoul, South Korea, the platform has attracted over 5,000 companies and hundreds of thousands of users. Notable clients include IBM, Facebook, Microsoft, eBay, WeWork, Rakuten, and Tencent, all of which utilize Wanted to identify and recruit top talent in Asia. Since its inception, Wantedlab has raised over $20 million in funding and is actively expanding its presence to major cities worldwide.

Standigm

Series B in 2019
Standigm, Inc. is a South Korean company founded in 2015 that specializes in artificial intelligence technologies for the pharmaceutical industry, focusing specifically on drug discovery. The company has developed proprietary AI platforms that streamline the drug development process, encompassing target identification, lead generation, and drug repurposing. Standigm's innovative workflow integrates advanced data parsing and biological interpretation to analyze biomedical data, allowing for the identification of valuable drug pipelines while minimizing traditional guesswork. Their automation technologies, including DarkMolFactory™, Standigm ASK™ for target discovery, and Standigm BEST™ for lead design, enable the rapid generation of First-in-Class lead compounds within a seven-month timeframe. By industrializing and automating the drug discovery process, Standigm aims to reduce both the time and cost associated with bringing new pharmaceuticals to market.

Triple

Series B in 2019
Triple is a travel data services startup that operates a travel booking application aimed at connecting travelers with the tourism industry. The application facilitates the booking of hotels and restaurants while offering essential information such as weather forecasts, currency exchange rates, directions, translation services, time difference calculations, and recommendations for sightseeing spots. By providing these comprehensive resources, Triple enables travelers to explore new destinations without the stress of making extensive travel arrangements in advance.

PR&D Company

Series B in 2019
PR&D Company designs and develops hey dealer app and website for car-selling services.

Brandi

Series B in 2019
Brandi is a vertical commerce company founded in 2014 and headquartered in Seoul, South Korea. It operates a retail platform specializing in the fashion and beauty sectors, providing both B2C and B2B shopping experiences. Brandi offers a diverse range of products, including clothing, cosmetics, and home interior items. The company focuses on creating a connected ecosystem that links manufacturers, wholesalers, and consumers, thereby aiding young individuals in engaging with current fashion trends. Through its platform, Brandi aims to make various clothing brands accessible to customers at affordable prices.

Immotor

Series B in 2018
Immotor is a Chinese company founded in 2016 by Daniel Huang, specializing in the development and sale of personal transport systems. Its primary products are the Immotor GO, a portable motorized scooter; the Immotor Super Battery, a power management source; and Immotor Cloud, a remote control and fleet management tool for Immotor GO. The company also offers intelligent battery swapping systems and electric bicycle battery-sharing services, aiming to promote cleaner energy through its zero-emission products.

AppOnboard

Series B in 2018
AppOnboard is a Los Angeles-based software company that provides tools for creators to develop mobile applications and interactive content without any programming knowledge. The company offers two primary products: Buildbox, the largest no-code mobile game engine, and AppOnboard Studio, a mobile design platform that allows users to create playable advertisements and app prototypes. By eliminating the need for coding, AppOnboard enables individuals and businesses to bring their ideas to life and share interactive experiences on application stores and social media platforms.

APR Corporation

Series B in 2018
APR Co., Ltd is a South Korean company established in 2014, specializing in the manufacture and sale of cosmetic products for both men and women. The company offers a diverse range of products, including medical cosmetics, diet products, and beauty devices. In addition to its core beauty offerings, APR operates an instant photo booth service and sells apparel such as caps, sweatshirts, and track tops through its online store. The company markets its products under several brand names, including APRILSKIN, medicube, GLAMD, Forment, Photogray ORAZIN, and NERDY. With a strong presence in both the domestic and international markets, particularly for its 'MediCube' brand, APR has established itself as a reputable player in the beauty and skincare industry.

Lunit

Series B in 2018
Lunit Inc. is a medical AI software company based in Seoul, South Korea, specializing in advanced algorithms for medical image analysis and general object detection. The company focuses on developing solutions that aid physicians in making objective diagnoses through machine learning technology. Lunit's expertise encompasses various medical imaging fields, including digital chest X-ray, digital mammography, digital pathology, and fundus photography. The company's products include Lunit INSIGHT CXR for chest X-rays, Lunit INSIGHT MMG for mammography, and Lunit SCOPE, which provides AI-powered biomarkers for immuno-oncology. Lunit aims to enhance clinical decision-making by leveraging data-driven imaging biomarker technology, ultimately improving the accuracy and efficiency of cancer care. The effectiveness of Lunit's deep learning technology has been validated through its recognition in major image recognition competitions, showcasing its capacity to process complex medical imaging data.

Moloco

Series B in 2018
Moloco Inc., founded in 2013 and based in Palo Alto, California, specializes in programmatic advertising solutions aimed at optimizing client acquisition, retention, and monetization strategies. The company offers a cloud-based demand-side platform that leverages machine learning to help businesses of all sizes enhance user acquisition and maximize lifetime value through predictive models. Additionally, Moloco provides a mobile e-commerce platform that supports targeted re-engagement campaigns, allowing application publishers and e-commerce platforms to expand their customer reach more effectively than traditional advertising methods. With a team comprised of top talents from leading tech firms, Moloco is committed to empowering mobile businesses to thrive in a competitive landscape.

Dr.Kitchen

Series B in 2017
Kitchen Doctor engages in research and development of diet programs for diabetes. Kitchen Doctor is based in Daejeon, South Korea with an additional office in Seoul, South Korea.

Blind

Series B in 2017
Blind is an anonymous professional network designed to facilitate open communication among verified professionals across various industries. With over 4.1 million users worldwide, the platform enables individuals to engage in private company channels with colleagues and participate in open forums for broader discussions. Users can share valuable insights, such as job offer details and honest feedback about company culture, without fear of judgment or retribution. Blind aims to promote transparency in the workplace, empowering professionals to make informed decisions and encouraging meaningful change within their organizations.

ImmunoMet Therapeutics

Series B in 2017
ImmunoMet Therapeutics, Inc. is a biopharmaceutical company based in Houston, Texas, dedicated to developing and commercializing innovative oncology drugs. Founded in 2015, the company focuses on improving the quality of life for cancer patients through its advanced pipeline of products. This includes metabolic regulators designed to target the cellular metabolism of drug-resistant cancer subpopulations, as well as immuno-suppressors aimed at anti-cancer effector T cells. With over six years of expertise in cancer metabolism and immunometabolism, ImmunoMet Therapeutics is positioned to make significant contributions to the field of oncology.

Earth Alliance

Series B in 2015
Earth Alliance is a collaboration on investment activities.

KAHR

Series B in 2015
KAHR Medical Ltd., established in 2005 and headquartered in Jerusalem, Israel, is a biopharmaceutical company specializing in immuno-oncology drug development. It focuses on creating fusion protein pharmaceuticals for treating cancer and autoimmune diseases. KAHR's proprietary technology involves developing 'third generation biological drugs,' which are unique fusion-protein molecules designed to activate immune responses by converting cancer cells' protective mechanisms into targets for the immune system. The company offers several candidates, including DSP105 and DSP106 for T-cell mediated tumor destruction, and DSP107 targeting CD47 tumors while delivering an immune costimulatory signal.

SMATOOS

Series B in 2015
SMATOOS (스마투스) is a Korean edtech startup that develops educational services including BeNative, BeNative Pro, and CashEnglish. BeNative Pro, launched in 2015, is the #1 English-learning service in Asia. It is currently being used by Samsung, LG, and over 2000 other companies and universities. BeNative, available on both iOS and Android devices, was released in July 2016 as a free download. Users get access to all content for free, while also being rewarded with weekly cash prizes generated from video ads. It's time to be rewarded for learning! The summer of 2016 also saw the release of CashEnglish and CashSpanish. These apps gamify language learning by also rewarding users with cash rewards. No risks involved. Just Play, Learn, Win! SMATOOS is a portmanteau of Koreanized English words meaning to "study smarter."

RIDI

Series B in 2014
RIDI Corporation is South Korea’s one of the largest digital content publication & distribution companies, mainly known for vitalizing the Korean e-book industry as well as empowering the web novel, webcomic, animation, articles, and news media. RIDI believes that rich imagination and deep insight serve as nutrients to make the human mind fertile and delivers them through its digital contents.

Ridibooks

Series B in 2014
Ridibooks is a content portal that contains webtoons, web novels, comics, and e-books. Ridibooks produce all the fun stories in the world with original content from North America to the world .From novels to economics and business books, only verified bestsellers are collected and provided.

RacoonSoft

Series B in 2014
RacoonSoft is a group of creative minds whom craving for luxury enjoyment and fun. Their goal is to become a friend to people all over the world presenting happiness through their games. Cute and adorable looking Racoon is their friendly mascot Racooni, who is acting as a connection between game users and RacoonSoft. Come and join the Exciting play of RacoonSoft!
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.